We are live on ! Find out more
TARO

Taro Pharmaceutical Industries Ltd.
TARO

Delisted

TARO was delisted on the 21st of June, 2024.

Back to rankings

133 hedge funds and large institutions have $633M invested in Taro Pharmaceutical Industries Ltd. in 2017 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 46 increasing their positions, 41 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

12% more repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 41

5% less funds holding

Funds holding: 140 → 133 (-7)

6% less capital invested

Capital invested by funds: $671M → $633M (-$38.2M)

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

47% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 15

99% less call options, than puts

Call options by funds: $36K | Put options by funds: $2.43M

Holders
133
Holders Change
-7
Holders Change %
-5%
% of All Funds
3.32%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
8
Increased
46
Reduced
41
Closed
15
Calls
$36K
Puts
$2.43M
Net Calls
-$2.4M
Net Calls Change
-$1.23M

Top Buyers

1
AL
AJO LP
Pennsylvania
+$18.1M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$5.05M
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$4.78M
4
BIP
Brandes Investment Partners
California
+$2.38M
5
Goldman Sachs
Goldman Sachs
New York
+$2.11M

Top Sellers

1
CG
Carmignac Gestion
France
-$16.5M
2
MICM
Matthews International Capital Management
California
-$16.5M
3
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
-$12.9M
4
RRAM
River Road Asset Management
Kentucky
-$7.34M
5
AAF
Andra AP-fonden
Sweden
-$4.58M
Name Holding Trade Value Shares
Change 		Change in
Stake
Asset Management One
26
Asset Management One
Japan
$4.74M +$733K +6,738 +19%
JAM
27
Jupiter Asset Management
United Kingdom
$4.58M – – –
AA
28
ALPS Advisors
Colorado
$4.5M +$311K +2,861 +8%
Geode Capital Management
29
Geode Capital Management
Massachusetts
$4M +$43.3K +398 +1%
California Public Employees Retirement System
30
California Public Employees Retirement System
California
$3.81M +$114K +1,051 +3%
AIIMS
31
Analyst IMS Investment Management Services
Israel
$3.52M – – –
Bank of New York Mellon
32
Bank of New York Mellon
New York
$3.44M +$47.4K +436 +1%
Mitsubishi UFJ Trust & Banking
33
Mitsubishi UFJ Trust & Banking
Japan
$3.18M +$2.5K +23 +0.1%
AAF
34
Andra AP-fonden
Sweden
$3.04M -$4.58M -42,100 -61%
Vanguard Group
35
Vanguard Group
Pennsylvania
$2.92M – – –
TCIM
36
TIAA CREF Investment Management
New York
$2.66M +$124K +1,136 +5%
Barclays
37
Barclays
United Kingdom
$2.61M -$950K -8,731 -27%
Royal Bank of Canada
38
Royal Bank of Canada
Ontario, Canada
$2.5M +$1.46M +13,383 +152%
BIP
39
Brandes Investment Partners
California
$2.46M +$2.38M +21,836 New
VRS
40
Virginia Retirement Systems
Virginia
$2.42M +$381K +3,500 +19%
Invesco
41
Invesco
Georgia
$2.33M +$513K +4,717 +30%
EF
42
Empirical Finance
Pennsylvania
$2.32M +$1.12M +10,257 +99%
UBS AM
43
UBS AM
Illinois
$2.18M +$3.7K +34 +0.2%
Los Angeles Capital Management
44
Los Angeles Capital Management
California
$2.13M -$3.54M -32,543 -63%
Bank of America
45
Bank of America
North Carolina
$2.13M -$319K -2,932 -13%
Caisse de Depot et Placement du Quebec (CDPQ)
46
Caisse de Depot et Placement du Quebec (CDPQ)
Quebec, Canada
$1.96M +$32.6K +300 +2%
RIA
47
RPG Investment Advisory
California
$1.89M -$39.1K -359 -2%
Morgan Stanley
48
Morgan Stanley
New York
$1.82M -$3.12M -28,656 -64%
ACI
49
AMP Capital Investors
Australia
$1.81M -$207K -1,900 -11%
CS
50
Credit Suisse
Switzerland
$1.77M +$81.8K +752 +5%
1
2
3 4 5

TARO Hedge Fund Activity: Q3 2017 in Review

133 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Taro Pharmaceutical Industries Ltd. (TARO) for Q3 2017, worth a combined $633M — down 5.7% from $671M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of TARO and 8 opened new positions — a net loss of 7 holders — while 41 trimmed existing stakes and 46 added.

The largest buyer was AJO LP, adding an estimated $18.1M. The largest seller was Carmignac Gestion, exiting entirely with an estimated $16.5M sold.

  • 133 institutional investors held Taro Pharmaceutical Industries Ltd. (TARO) as of Q3 2017, down from 140 in Q2 2017.
  • Funds reported $633M of Taro Pharmaceutical Industries Ltd. stock for Q3 2017, down 5.7% quarter-over-quarter.
  • 8 funds opened new Taro Pharmaceutical Industries Ltd. positions in Q3 2017 and 15 closed out, a net change of -7 holders.
  • The largest Taro Pharmaceutical Industries Ltd. buyer in Q3 2017 was AJO LP, an estimated $18.1M added.
  • The largest Taro Pharmaceutical Industries Ltd. seller in Q3 2017 was Carmignac Gestion, an estimated $16.5M sold.

Based on aggregated 13F filings for Q3 2017.